Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Aug;52(2):159–165. doi: 10.1038/bjc.1985.172

Flow cytometric light chain analysis of peripheral blood lymphocytes in patients with non-Hodgkin's lymphoma.

A Johnson, E Cavallin-Ståhl, M Akerman
PMCID: PMC1977117  PMID: 3927967

Abstract

Peripheral blood lymphocytes from 96 patients with non-Hodgkin's lymphoma were studied, either at primary staging, during treatment or in follow up. The amount of surface immunoglobulin light chain per cell was determined by direct immunofluorescence staining analysed by flow cytometry. Discrepancy between kappa and lambda fluorescence profiles in the sample was considered to indicate the presence of monoclonal cells i.e., circulating lymphoma cells. The results were correlated with routine haematological findings, histopathology of the lymphoma and tumour burden. Using routine haematological methods leukaemic spread was evident in 24% of the patients in our study. Using kappa/lambda distribution analysis evidence of circulating lymphoma cells was found in an additional 27%. As expected, the major diagnostic gain was in the low grade malignant group, where 30% of the patients with normal peripheral blood according to standard procedures showed evidence of circulating lymphoma cells in the kappa/lambda distribution analysis. The corresponding gain in the high grade malignant group was 19%. In patients with active disease but without morphological evidence of leukaemia, 37% showed abnormal kappa/lambda distributions. In patients in complete remission the corresponding figure was 18%. The clinical significance of small numbers of circulating lymphoma cells is not yet understood, but a possible outlook is to use kappa/lambda distribution analysis to increase staging precision and in the early detection of relapse.

Full text

PDF
159

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisenberg A. C., Long J. C. Lymphocyte surface characteristics in malignant lymphoma. Am J Med. 1975 Mar;58(3):300–306. doi: 10.1016/0002-9343(75)90595-1. [DOI] [PubMed] [Google Scholar]
  2. Ault K. A. Detection of small numbers of monoclonal B lymphocytes in the blood of patients with lymphoma. N Engl J Med. 1979 Jun 21;300(25):1401–1405. doi: 10.1056/NEJM197906213002501. [DOI] [PubMed] [Google Scholar]
  3. Cader A., Richardson P., Walsh L., Ling N. R., MacLennan I. C., Jones E. L., Leyland M. The incidence of B cell leukaemia and lymphopenia in B cell neoplasia in adults: a study using the Kiel classification of non-Hodgkin's lymphoma. Br J Cancer. 1983 Aug;48(2):185–193. doi: 10.1038/bjc.1983.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Garrett J. V., Scarffe J. H., Newton R. K. Abnormal peripheral blood lymphocytes and bone marrow infiltration in non-Hodgkin's lymphoma. Br J Haematol. 1979 May;42(1):41–50. doi: 10.1111/j.1365-2141.1979.tb03696.x. [DOI] [PubMed] [Google Scholar]
  5. Grey H. M., Rabellino E., Pirofsky B. Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemia. J Clin Invest. 1971 Nov;50(11):2368–2375. doi: 10.1172/JCI106735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Habeshaw J. A., Bailey D., Stansfeld A. G., Greaves M. F. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques. Br J Cancer. 1983 Mar;47(3):327–351. doi: 10.1038/bjc.1983.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Heifetz L. J., Fuller L. M., Rodgers R. W., Martin R. G., Butler J. J., North L. B., Gamble J. F., Shullenberger C. C. Laparotomy findings in lymphangiogram-staged I and non-Hodgkin's lymphomas. Cancer. 1980 Jun 1;45(11):2778–2786. doi: 10.1002/1097-0142(19800601)45:11<2778::aid-cncr2820451112>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  8. Killander D., Johansson B., Haglund S. Immunofluorometric analyses of membrane bound IgM in individual human lymphoid cells in cases of leukemia and malignant lymphoma. Haematol Blood Transfus. 1977;20:147–156. doi: 10.1007/978-3-642-66639-1_15. [DOI] [PubMed] [Google Scholar]
  9. Kumagai K., Abo T., Sekizawa T., Sasaki M. Studies of surface immunoglobulins on human B lymphocytes. I. Dissociation of cell-bound immunoglobulins with acid pH or at 37 degrees C. J Immunol. 1975 Oct;115(4):982–987. [PubMed] [Google Scholar]
  10. Levy R., Warnke R., Dorfman R. F., Haimovich J. The monoclonality of human B-cell lymphomas. J Exp Med. 1977 Apr 1;145(4):1014–1028. doi: 10.1084/jem.145.4.1014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ligler F. S., Kettman J. R., Smith R. G., Frenkel E. P. Immunoglobulin phenotype on B cells correlates with clinical stage of chronic lymphocytic leukemia. Blood. 1983 Aug;62(2):256–263. [PubMed] [Google Scholar]
  12. Ligler F. S., Smith R. G., Kettman J. R., Hernandez J. A., Himes J. B., Vitetta E. S., Uhr J. W., Frenkel E. P. Detection of tumor cells in the peripheral blood of nonleukemic patients with B-cell lymphoma: analysis of "clonal excess". Blood. 1980 May;55(5):792–801. [PubMed] [Google Scholar]
  13. Ligler F. S., Vitetta E. S., Smith R. G., Himes J. B., Uhr J. W., Frenkel E. P., Kettman J. R. An immunologic approach for the detection of tumor cells in the peripheral blood of patients with malignant lymphoma; implications for the diagnosis of minimal disease. J Immunol. 1979 Sep;123(3):1123–1126. [PubMed] [Google Scholar]
  14. Lobo P. I., Westervelt F. B., Horwitz D. A. Identification of two populations of immunoglobulin-bearing lymphocytes in man. J Immunol. 1975 Jan;114(1 Pt 1):116–119. [PubMed] [Google Scholar]
  15. Lukes R. J., Taylor C. R., Parker J. W., Lincoln T. L., Pattengale P. K., Tindle B. H. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias. Am J Pathol. 1978 Feb;90(2):461–486. [PMC free article] [PubMed] [Google Scholar]
  16. McKelvey E. M., Moon T. E. Curability of non-Hodgkin's lymphomas. Cancer Treat Rep. 1977 Sep;61(6):1185–1190. [PubMed] [Google Scholar]
  17. Preud'homme J. L., Seligmann M. Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases. Blood. 1972 Dec;40(6):777–794. [PubMed] [Google Scholar]
  18. Slease R. B., Wistar R., Jr, Scher I. Surface immunoglobulin density on human peripheral blood mononuclear cells. Blood. 1979 Jul;54(1):72–87. [PubMed] [Google Scholar]
  19. Swerdlow S. H., Habeshaw J. A., Murray L. J., Dhaliwal H. S., Lister T. A., Stansfeld A. G. Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse. Am J Pathol. 1983 Nov;113(2):181–197. [PMC free article] [PubMed] [Google Scholar]
  20. Teodorescu M., Mayer E. P. Surface immunoglobulin in immunoproliferative diseases. Ann Clin Lab Sci. 1978 Sep-Oct;8(5):353–365. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES